These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7496150)

  • 1. Expression of the T antigen on a T-lymphoid cell line, supT1.
    Nakada H; Inoue M; Tanaka N; Wakamiya N; Yamashina I
    Glycoconj J; 1995 Jun; 12(3):356-9. PubMed ID: 7496150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural variations of O-linked oligosaccharides present in leukosialin isolated from erythroid, myeloid, and T-lymphoid cell lines.
    Carlsson SR; Sasaki H; Fukuda M
    J Biol Chem; 1986 Sep; 261(27):12787-95. PubMed ID: 2943741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tn antigen is expressed on leukosialin from T-lymphoid cells.
    Inoue M; Nakada H; Tanaka N; Yamashina I
    Cancer Res; 1994 Jan; 54(1):85-8. PubMed ID: 8261467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthesis of truncated O-glycans in the T cell line Jurkat. Localization of O-glycan initiation.
    Piller V; Piller F; Fukuda M
    J Biol Chem; 1990 Jun; 265(16):9264-71. PubMed ID: 2140570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly-N-acetyllactosaminyl O-glycans attached to leukosialin. The presence of sialyl Le(x) structures in O-glycans.
    Maemura K; Fukuda M
    J Biol Chem; 1992 Dec; 267(34):24379-86. PubMed ID: 1447188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the Tn antigen on T-lymphoid cell line Jurkat.
    Nakada H; Inoue M; Tanaka N; Numata Y; Kitagawa H; Fukui S; Yamashina I
    Biochem Biophys Res Commun; 1991 Sep; 179(2):762-7. PubMed ID: 1716888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a differentiation antigen and poly-N-acetyllactosaminyl O-glycans directed by a cloned core 2 beta-1,6-N-acetylglucosaminyltransferase.
    Bierhuizen MF; Maemura K; Fukuda M
    J Biol Chem; 1994 Feb; 269(6):4473-9. PubMed ID: 8308016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus type 1-infected individuals make autoantibodies that bind to CD43 on normal thymic lymphocytes.
    Ardman B; Sikorski MA; Settles M; Staunton DE
    J Exp Med; 1990 Oct; 172(4):1151-8. PubMed ID: 1976735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis.
    Piller F; Piller V; Fox RI; Fukuda M
    J Biol Chem; 1988 Oct; 263(29):15146-50. PubMed ID: 2971663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-glycosylation of leukosialin in K562 cells. Evidence for initiation and elongation in early Golgi compartments.
    Piller V; Piller F; Klier FG; Fukuda M
    Eur J Biochem; 1989 Jul; 183(1):123-35. PubMed ID: 2526734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression cloning of a cDNA encoding UDP-GlcNAc:Gal beta 1-3-GalNAc-R (GlcNAc to GalNAc) beta 1-6GlcNAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigen.
    Bierhuizen MF; Fukuda M
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9326-330. PubMed ID: 1329093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies directed against CD43 molecules with an altered glycosylation status on human immunodeficiency virus type 1 (HIV-1)-infected CEM cells are found in all HIV-1+ individuals.
    Giordanengo V; Limouse M; Desroys du Roure L; Cottalorda J; Doglio A; Passeron A; Fuzibet JG; Lefebvre JC
    Blood; 1995 Sep; 86(6):2302-11. PubMed ID: 7662977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered O-glycan synthesis in lymphocytes from patients with Wiskott-Aldrich syndrome.
    Piller F; Le Deist F; Weinberg KI; Parkman R; Fukuda M
    J Exp Med; 1991 Jun; 173(6):1501-10. PubMed ID: 2033371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-lymphocytic leukemia expresses complex, branched O-linked oligosaccharides on a major sialoglycoprotein, leukosialin.
    Saitoh O; Piller F; Fox RI; Fukuda M
    Blood; 1991 Apr; 77(7):1491-9. PubMed ID: 1826222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukosialin, a major sialoglycoprotein defining leucocyte differentiation.
    Fukuda M
    Ciba Found Symp; 1989; 145():257-68; discussion 268-76. PubMed ID: 2529107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of aberrant O-glycans attached to leukosialin in differentiation-deficient HL-60 cells.
    Saitoh O; Gallagher RE; Fukuda M
    Cancer Res; 1991 Jun; 51(11):2854-62. PubMed ID: 1827755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered glycosylation of leukosialin, CD43, in HIV-1-infected cells of the CEM line.
    Lefebvre JC; Giordanengo V; Limouse M; Doglio A; Cucchiarini M; Monpoux F; Mariani R; Peyron JF
    J Exp Med; 1994 Nov; 180(5):1609-17. PubMed ID: 7964449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucin-type O-glycans and leukosialin.
    Fukuda M; Tsuboi S
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):205-17. PubMed ID: 10571013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of CD43 and other lymphocyte O-glycoproteins by core 2 N-acetylglucosaminyltransferase.
    Barran P; Fellinger W; Warren CE; Dennis JW; Ziltener HJ
    Glycobiology; 1997 Feb; 7(1):129-36. PubMed ID: 9061371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered T cell surface glycosylation in HIV-1 infection results in increased susceptibility to galectin-1-induced cell death.
    Lantéri M; Giordanengo V; Hiraoka N; Fuzibet JG; Auberger P; Fukuda M; Baum LG; Lefebvre JC
    Glycobiology; 2003 Dec; 13(12):909-18. PubMed ID: 12925577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.